Neurohormonal activation late after cavopulmonary connection

Heart

Volumn 83, Issue 4, 2000, Pages 439-443

  Hjortdal, V E ^a   Stenbog E V ^a   Ravn, H B ^a   Emmertsen, K ^a   Jensen, K T ^a   Pedersen, E B ^b   Olsen, K H ^a   Hansen, O K ^a   Sorensen K E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HOLSTEBRO HOSPITAL   (Denmark)

Author keywords

Cavopulmonary connection; Congenital heart disease; Neurohormones; Paediatric cardiology

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ARGININE; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; COUMARIN ANTICOAGULANT; DIURETIC AGENT; NEUROHORMONE; RENIN; VASOPRESSIN;

ADAPTATION; ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL SHUNT; CAVA VEIN; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY VEIN;

EID: 0034025039     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.4.439     Document Type: Article

References (39)

1. Harrison DA, Liu P, Walters JE, et al. Cardiopulmonary function in adult patients late after Fontan repair. J Am Coll Cardiol 1995;26:1016-21.
2. Rosenthal M, Bush A, Deanfield J, et al. Comparison of cardiopulmonary adaptation during exercise in children after the atriopulmonary and total cavopulmonary connection Fontan procedures. Circulation 1995;91:372-8.
3. Reybrouck T, Rogers R, Weymans M, et al. Serial cardiorespiratory exercise testing in patients with congenital heart disease. Eur J Pediatr 1995;154:801-6.
4. Norgård G, Gatzoulis MA. Value of exercise testing in the assessment of the Fontan operation. Cardiol Young 1996;6:106-8.
5. Mertens L, Rogers R, Reybrouck T, et al. Cardiopulmonary response to exercise after the Fontan operation: a cross-sectional and longitudinal evaluation. Cardiol Young 1996;6:136-42.
6. Troutman WB, Barstow TJ, Galindo AJ, et al. Abnormal dynamic cardiorespiratory responses to exercise in pediatric patients after Fontan procedure. J Am Coll Cardiol 1998;31:668-73.
7. Kiana A, Shakibi JG. Fontan physiology. Circulation 1995;92:3149-50.
8. Kelly JR, Mack GW, Fhey JT. Diminished venous vascular capacitance in patient with univentricular hearts after the Fontan operation. Am J Cardiol 1995;76:158-63.
9. The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316:1429-35.
10. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
11. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
12. Vantrimpont P, Rouleau JL, Ciampi A, et al. (for the SAVE investigators). Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J 1998;19:52-63.
13. Mainwaring RD, Lamberti JJ, Moore JW, et al. Comparison of the hormonal response after bidirectional Glenn and Fontan procedure. Ann Thorac Surg 1994;57:59-64.
14. Kappelgaard AM, Damkjaer Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976;67:299-306.
15. Rask-Madsen J, Bruusgaard A, Munck O, et al. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1974;9:417-26.
16. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984;26:543-47.
17. Thomassen A, Bagger JP, Nielsen TT, et al. Atrial natriuretic peptide during pacing in controls and patients with coronary artery disease. Int J Cardiol 1987;17:267-76.
18. Jensen KT, Carstens J, Ivarsen P, et al. A new, fast and reliable radioimmuno-assay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997;57:529-40.
19. Komajda M, Isnard R, Lechat P. The role of the neurohormonal system in heart failure. Heart 1998;79(suppl 2):S17-23.
20. Francis GS, McDonald KM, Cohn JN. Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention. Circulation 1993;87(suppl IV):IV-90-6.
21. Pitt B, Segal R, Martinez FA, et al (on behalf of ELITE study investigators). Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-52.
22. Nagaya N, Nishikimi T, Uematsu M, et al. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 1998;136:297-301.
23. Kindelan AA, Navaro JLP, de la Rosa, et al. Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease. Crit Care Med 1994;22:1754-61.
24. Stewart JM, Seligman KP, Zeballos G, et al. Elevated natriuretic peptide after the Fontan procedure. Circulation 1987;76(suppl III):III-77-82.
25. Stewart JM, Gewitz MH, Clarke BJ, et al. The role of vasopressin and atrial natriuretic factor in postoperative fluid retention after the Fontan procedure. J Thorac Cardiovasc Surg 1991;102:821-9.
26. Nagaoka H, Innami R, Arai H. Effects of pulsatile cardiopulmonary bypass on the renin-angiotensin-aldosterone system following open heart surgery. Jpn J Surg 1988;18:390-6.
27. Morgan HE, Baker KM. Cardiac hypertrophy; mechanical, neural, and endocrine dependence. Circulation 1991;83:14-25.
28. Kato H, Suzuki H, Tajima S, et al. Angiotensin II stimulates collagen synthesis in the cultured vascular smooth muscle cells. J Hypertens 1991;9:17-22.
29. Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
30. Geggel RL. Update on the modified Fontan procedure. Curr Opin Cardiol 1997;12:51-62.
31. Hill NS, Klinger JR, Warburton RR, et al. Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension. Am J Physiol 1994;266:L308-15.
32. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
33. Hiramatsu T, Imai Y, Takanashi Y, et al. Hemodynamic effects of human atrial natriuretic peptide after modified Fontan procedure. Ann Thorac Surg 1998;65:761-4.
34. Burnett JC, Kao PC, Hu DC, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986;231:1145-7.
35. Fiselier TJW, Lijnen P, Mionnens L, et al. Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood. Eur J Pediatr 1983;141:3-7.
36. Perrault H, Miro J, Davignon A, et al. Decreased plasma atriopeptin response to volume-overloading maneuvers and exercise after atriopulmonary anastomosis of Fontan. Am J Cardiol 1992;69:1325-8.
37. Hirsch AT, Dzau VJ. Tissue renin angiotensin system in the pathophysiology of heart failure. In: Brachmann J, Dietz R, Kubler W, eds. Heart failure and arrhythmias. Heidelberg: Springer-Verlag, 1990:33-42.
38. Bengur AR, Beekman RH, Rocchini AP, et al. Acute hemodynamic effects of captopril in children with a congestive or restrictive cardiomyopathy. Circulation 1991;83:523-7.
39. Kouatli AA, Garcia JA, Zeller TM, et al. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation 1997;96:1507-12.